Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search.

Bonaventura, Jordi; Gomez, Juan L; Carlton, Meghan L; Lam, Sherry; Sanchez-Soto, Marta; Morris, Patrick J; Moaddel, Ruin; Kang, Hye Jin; Zanos, Panos; Gould, Todd D; Thomas, Craig J; Sibley, David R; Zarate, Carlos A; Michaelides, Michael.

Mol Psychiatry ; 27(10): 4144-4156, 2022 10.

Artículo en Inglés | MEDLINE | ID: mdl-35768639

2.

Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D₁ Dopamine Receptor and Their Roles in Modulating ß-Arrestin Binding and Activation.

Moritz, Amy E; Madaras, Nora S; Rankin, Michele L; Inbody, Laura R; Sibley, David R.

Int J Mol Sci ; 24(7)2023 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-37047571

3.

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.

Bonaventura, Jordi; Lam, Sherry; Carlton, Meghan; Boehm, Matthew A; Gomez, Juan L; Solís, Oscar; Sánchez-Soto, Marta; Morris, Patrick J; Fredriksson, Ida; Thomas, Craig J; Sibley, David R; Shaham, Yavin; Zarate, Carlos A; Michaelides, Michael.

Mol Psychiatry ; 26(11): 6704-6722, 2021 11.

Artículo en Inglés | MEDLINE | ID: mdl-33859356

4.

Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D₂ Dopamine Receptor.

Free, R Benjamin; Cuoco, Caroline A; Xie, Bing; Namkung, Yoon; Prabhu, Varun V; Willette, Blair K A; Day, Marilyn M; Sanchez-Soto, Marta; Lane, J Robert; Laporte, Stéphane A; Shi, Lei; Allen, Joshua E; Sibley, David R.

Mol Pharmacol ; 100(4): 372-387, 2021 10.

Artículo en Inglés | MEDLINE | ID: mdl-34353882

5.

New roles for dopamine D₂ and D₃ receptors in pancreatic beta cell insulin secretion.

Farino, Zachary J; Morgenstern, Travis J; Maffei, Antonella; Quick, Matthias; De Solis, Alain J; Wiriyasermkul, Pattama; Freyberg, Robin J; Aslanoglou, Despoina; Sorisio, Denise; Inbar, Benjamin P; Free, R Benjamin; Donthamsetti, Prashant; Mosharov, Eugene V; Kellendonk, Christoph; Schwartz, Gary J; Sibley, David R; Schmauss, Claudia; Zeltser, Lori M; Moore, Holly; Harris, Paul E; Javitch, Jonathan A; Freyberg, Zachary.

Mol Psychiatry ; 25(9): 2070-2085, 2020 09.

Artículo en Inglés | MEDLINE | ID: mdl-30626912

6.

Development of pyrimidone D1 dopamine receptor positive allosteric modulators.

Luderman, Kathryn D; Jain, Prashi; Benjamin Free, R; Conroy, Jennie L; Aubé, Jeffrey; Sibley, David R; Frankowski, Kevin J.

Bioorg Med Chem Lett ; 31: 127696, 2021 01 01.

Artículo en Inglés | MEDLINE | ID: mdl-33221389

7.

The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.

Verma, Ravi Kumar; Abramyan, Ara M; Michino, Mayako; Free, R Benjamin; Sibley, David R; Javitch, Jonathan A; Lane, J Robert; Shi, Lei.

PLoS Comput Biol ; 14(1): e1005948, 2018 01.

Artículo en Inglés | MEDLINE | ID: mdl-29337986

8.

A new era of rationally designed antipsychotics.

Sibley, David R; Shi, Lei.

Nature ; 555(7695): 170-172, 2018 03 08.

Artículo en Inglés | MEDLINE | ID: mdl-29517027

9.

A new era of rationally designed antipsychotics.

Sibley, David R; Shi, Lei.

Nature ; 555(7695): 170-172, 2018 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-32095019

10.

Identification of Positive Allosteric Modulators of the D₁ Dopamine Receptor That Act at Diverse Binding Sites.

Luderman, Kathryn D; Conroy, Jennie L; Free, R Benjamin; Southall, Noel; Ferrer, Marc; Sanchez-Soto, Marta; Moritz, Amy E; Willette, Blair K A; Fyfe, Tim J; Jain, Prashi; Titus, Steve; Hazelwood, Lisa A; Aubé, Jeffrey; Lane, J Robert; Frankowski, Kevin J; Sibley, David R.

Mol Pharmacol ; 94(4): 1197-1209, 2018 10.

Artículo en Inglés | MEDLINE | ID: mdl-30068735

11.

The show must go on. Reply to "Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al" by Insop Shim.

Bonaventura, Jordi; Lam, Sherry; Carlton, Meghan; Boehm, Matthew; Gomez, Juan L; Solís, Oscar; Sánchez-Soto, Marta; Morris, Patrick J; Fredriksson, Ida; Thomas, Craig J; Sibley, David R; Shaham, Yavin; Zarate, Carlos A; Michaelides, Michael.

Mol Psychiatry ; 2022 Jun 22.

Artículo en Inglés | MEDLINE | ID: mdl-35732692

12.

Time will tell. Reply to "Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al." by Chen et al.

Bonaventura, Jordi; Lam, Sherry; Carlton, Meghan; Boehm, Matthew; Gomez, Juan L; Solís, Oscar; Sánchez-Soto, Marta; Morris, Patrick J; Fredriksson, Ida; Thomas, Craig J; Sibley, David R; Shaham, Yavin; Zarate, Carlos A; Michaelides, Michael.

Mol Psychiatry ; 27(4): 1863-1865, 2022 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-35194167

13.

Discovery and characterization of a G protein-biased agonist that inhibits ß-arrestin recruitment to the D2 dopamine receptor.

Free, R Benjamin; Chun, Lani S; Moritz, Amy E; Miller, Brittney N; Doyle, Trevor B; Conroy, Jennie L; Padron, Adrian; Meade, Julie A; Xiao, Jingbo; Hu, Xin; Dulcey, Andrés E; Han, Yang; Duan, Lihua; Titus, Steve; Bryant-Genevier, Melanie; Barnaeva, Elena; Ferrer, Marc; Javitch, Jonathan A; Beuming, Thijs; Shi, Lei; Southall, Noel T; Marugan, Juan J; Sibley, David R.

Mol Pharmacol ; 86(1): 96-105, 2014 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-24755247

14.

Dopamine D1-like receptors regulate the α1A-adrenergic receptor in human renal proximal tubule cells and D1-like dopamine receptor knockout mice.

Ennis, Riley Charles; Asico, Laureano D; Armando, Ines; Yang, Jian; Feranil, Jun B; Jurgens, Julie A; Escano, Crisanto S; Yu, Peiying; Wang, Xiaoyan; Sibley, David R; Jose, Pedro A; Villar, Van Anthony M.

Am J Physiol Renal Physiol ; 307(11): F1238-48, 2014 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-25339698

15.

Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes.

Maison, Stéphane F; Liu, Xiao-Ping; Eatock, Ruth Anne; Sibley, David R; Grandy, David K; Liberman, M Charles.

J Neurosci ; 32(1): 344-55, 2012 Jan 04.

Artículo en Inglés | MEDLINE | ID: mdl-22219295

16.

D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.

Chun, Lani S; Free, R Benjamin; Doyle, Trevor B; Huang, Xi-Ping; Rankin, Michele L; Sibley, David R.

Mol Pharmacol ; 84(2): 190-200, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23680635

17.

Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

Bergman, Jack; Roof, Rebecca A; Furman, Cheryse A; Conroy, Jennie L; Mello, Nancy K; Sibley, David R; Skolnick, Phil.

Int J Neuropsychopharmacol ; 16(2): 445-58, 2013 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-22827916

18.

Dopamine receptor divergence revealed using a common ligand.

Sibley, David R; Nilson, Ashley N; Moritz, Amy E; Shi, Lei.

Trends Pharmacol Sci ; 44(10): 637-639, 2023 10.

Artículo en Inglés | MEDLINE | ID: mdl-37599183

19.

G Protein-Coupled Receptor Kinase 2 Selectively Enhances ß-Arrestin Recruitment to the D₂ Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation.

Sánchez-Soto, Marta; Boldizsar, Noelia M; Schardien, Kayla A; Madaras, Nora S; Willette, Blair K A; Inbody, Laura R; Dasaro, Christopher; Moritz, Amy E; Drube, Julia; Haider, Raphael S; Free, R Benjamin; Hoffman, Carsten; Sibley, David R.

Biomolecules ; 13(10)2023 10 20.

Artículo en Inglés | MEDLINE | ID: mdl-37892234

20.

Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors.

Enriquez-Traba, Juan; Yarur-Castillo, Hector E; Flores, Rodolfo J; Weil, Tenley; Roy, Snehashis; Usdin, Ted B; LaGamma, Christina T; Arenivar, Miguel; Wang, Huikun; Tsai, Valerie S; Moritz, Amy E; Sibley, David R; Moratalla, Rosario; Freyberg, Zachary Z; Tejeda, Hugo A.

bioRxiv ; 2023 Jun 28.

Artículo en Inglés | MEDLINE | ID: mdl-37425766

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search.

Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D₁ Dopamine Receptor and Their Roles in Modulating ß-Arrestin Binding and Activation.

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.

Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D₂ Dopamine Receptor.

New roles for dopamine D₂ and D₃ receptors in pancreatic beta cell insulin secretion.

Development of pyrimidone D1 dopamine receptor positive allosteric modulators.

The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.

A new era of rationally designed antipsychotics.

A new era of rationally designed antipsychotics.

Identification of Positive Allosteric Modulators of the D₁ Dopamine Receptor That Act at Diverse Binding Sites.

The show must go on. Reply to "Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al" by Insop Shim.

Time will tell. Reply to "Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al." by Chen et al.

Discovery and characterization of a G protein-biased agonist that inhibits ß-arrestin recruitment to the D2 dopamine receptor.

Dopamine D1-like receptors regulate the α1A-adrenergic receptor in human renal proximal tubule cells and D1-like dopamine receptor knockout mice.

Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes.

D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.

Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

Dopamine receptor divergence revealed using a common ligand.

G Protein-Coupled Receptor Kinase 2 Selectively Enhances ß-Arrestin Recruitment to the D₂ Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation.

Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors.